←back to thread

108 points pseudolus | 2 comments | | HN request time: 0.478s | source
Show context
pedalpete ◴[] No.45307457[source]
There is a growing body of research showing that increasing slow-wave activity during sleep can improve outcomes, including sleep quality[1], memory, and correlations with amyloid response[2].

Sadly, our latest grant application did not receive funding, but we are supporting other clinical researchers with our technology. Our technology is based on more than a decade of research with 50+ published, peer reviewed studies.

We focus on sleep directly rather than the disease, which means people do not have to wait years for regulatory approvals before they can feel day-to-day benefits.

For those curious about learning more, our approach and links to additional research are on our website https://affectablesleep.com .

Mild-to-moderate Alzheimer’s changes in sleep https://doi.org/10.1016/j.jagp.2024.07.002

Slow-wave activity, memory, and amyloid response https://doi.org/10.1093/ageing/afad228

replies(7): >>45307873 #>>45308485 #>>45309702 #>>45310561 #>>45311025 #>>45311227 #>>45311514 #
Citizen8396 ◴[] No.45308485[source]
What do you do with user data?
replies(1): >>45308642 #
pedalpete ◴[] No.45308642[source]
We don’t sell or share EEG data with third parties. The data is encrypted on the device and in storage. Our system processes it to show the user how they respond to stimulation, but company staff do not have direct access to individual user data. Internally we only look at anonymized or aggregated data to improve the technology.

Is that what you meant? I assumed you meant from a privacy perspective.

replies(1): >>45308855 #
1. octaane ◴[] No.45308855[source]
Are you planning on allowing this device to work with Android? I'm asking because I can see on your website that it requires an iphone currently.
replies(1): >>45309537 #
2. pedalpete ◴[] No.45309537[source]
Yeah, we definitely will have Android.

Almost everyone on our team is on Android, but we wanted to iterate on the platform that most users are on and focus on getting that experience right.

Sales will somewhat depend on when we bring on someone to pick up the Android front-end.

We're a really small team, and with hardware, firmware, services, and apps, the engineering footprint becomes quite large.

What often doesn't get factored in is manufacturing test rigs, plus we have software to support clinical research.

I'm not complaining about it, but holding off on Android seemed to be the right move, as we can't remove any of the other functions. We've had quite a few requests for Android.